Hanmi Pharm Releases Individually Packaged Stick-Type Children's Antipyretic

[Asia Economy Reporter Choi Dae-yeol] Hanmi Pharm has newly launched the pediatric antipyretic 'Maxibu Kids Syrup.' It is a formulation of Maxibufen Syrup, which was the first in Korea to be recognized for its efficacy and safety through Phase 3 clinical trials targeting young children, now available in a squeezable form.

Individually packaged for convenience, it reduces the inconvenience of having to measure a consistent amount each time it is taken. The new product's main ingredient is dexibuprofen, an active component isolated from ibuprofen, which is known to achieve the same effect at a lower dose than ibuprofen. Separating the active ingredient enhances safety.

Maxibu Kids Syrup comes in 6ml single-dose stick packs, with 10 sticks per box. For each dose, simply squeeze out one stick and take it as is. A company representative stated, "Maxibufen is a product proven to have fast effects and safety to the extent that it is a household essential medicine for families raising children. While the existing Maxibufen Syrup is for home use, Maxibu Kids Syrup will be useful for outings or emergencies."

This content was produced with the assistance of AI translation services.